Efficacy and Safety in a Randomised Acute Pain Study of MR308 (Tramadol/Celecoxib).

NCT02982161 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

818

Enrollment

INDUSTRY

Sponsor class

Conditions

Acute Pain

Interventions

DRUG: MR308
DRUG: Tramadol
DRUG: Placebo

Sponsor

Mundipharma Research GmbH & Co KG